3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Prostatic Neoplasms
3
Lymphoma
2
The Neoadjuvant Therapy
1
Sarcoma, Ewing
1
Sarcoma
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Interventions
regorafenib
1
Vincristine
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ifosfamide
1
Fluorodeoxyglucose F18
1
Etoposide
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Sarcoma, Ewing
×
Triptorelin Pamoate
×
Clear all
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled